We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Altered Faecal Protease Activity in Irritable Bowel Syndrome Patients in China

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2010 by Health Science Center of Xi’an Jiaotong University.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT01060527
First Posted: February 2, 2010
Last Update Posted: February 2, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Health Science Center of Xi’an Jiaotong University
  Purpose
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder haracterised by abdominal pain or discomfort associated with altered bowel habits,while the mechanism is still not understood.Recent advances have conceptualized the faecal supernatants of diarrhoea-predominant IBS have a substantially higher serine protease activity, while in china,almost no studies have reported about protease activity in IBS.

Condition
Irritable Bowel Syndrome

Study Type: Observational
Study Design: Observational Model: Case Control

Further study details as provided by Health Science Center of Xi’an Jiaotong University:

Estimated Enrollment: 60
Study Start Date: January 2010
Groups/Cohorts
IBS-D
IBS-C
Controll

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Outpatients in the second affiliated hospital of xi'an jiaotong university
Criteria

Inclusion Criteria:

  • Patients fulfilling the Rome III criteria for IBS participated in the study -

Exclusion Criteria:

  • Organic gastrointestinal disorders were excluded by detailed blood and stool analyses, serological assays and colonoscopy.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: the second affiliated hospital of xi'an jiaotong university
ClinicalTrials.gov Identifier: NCT01060527     History of Changes
Other Study ID Numbers: xi'an JTU091202
First Submitted: February 1, 2010
First Posted: February 2, 2010
Last Update Posted: February 2, 2010
Last Verified: January 2010

Keywords provided by Health Science Center of Xi’an Jiaotong University:
irritable bowel syndrome,protease activity,China

Additional relevant MeSH terms:
Syndrome
Irritable Bowel Syndrome
Disease
Pathologic Processes
Colonic Diseases, Functional
Colonic Diseases
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases